Ki67 expression in the primary tumor predicts for clinical benefit and time to progression on first-line endocrine therapy in estrogen receptor-positive metastatic breast cancer

By Delpech Y.  

Breast Cancer Research and Treatment, Vol. 135, Iss. 2, 2012-09 ,pp. : 619-627

Springer Publishing Company

Access to resources Recommend Favorite

Association between preoperative plasma levels of tissue inhibitor of metalloproteinases 1 and rectal cancer patient survival - a validation study

By Holten-Andersen M.   Christensen I.J.   Nilbert M.   Bendahl P.O.   Nielsen H.J.   Brunner N.   Fernebro E.  

European Journal of Cancer, Vol. 40, Iss. 1, 2004-01 ,pp. : 64-72

Elsevier

Access to resources Recommend Favorite

Tissue Inhibitor of Metalloproteinases-1 Stimulates Gene Expression in MDA-MB-435 Human Breast Cancer Cells by Means of its Ability to Inhibit Metalloproteinases

By Porter Joseph   Sharma Shashi   Wilson Donna   Kappil Maya   Hart Ronald   Denhardt David  

Breast Cancer Research and Treatment, Vol. 94, Iss. 2, 2005-11 ,pp. : 185-193

Springer Publishing Company

Access to resources Recommend Favorite

Association of steroid receptor coactivator AIB1 with estrogen receptor-α in breast cancer cells

By Azorsa D.O.   Cunliffe H.E.   Meltzer P.S.  

Breast Cancer Research and Treatment, Vol. 70, Iss. 2, 2001-11 ,pp. : 89-101

Springer Publishing Company

Access to resources Recommend Favorite

Association among the expression of β-catenin, cyclin D1 and estrogen receptor-β in human breast cancer

By          

Experimental and Therapeutic Medicine, Vol. 10, Iss. 4, 2015-01 ,pp. : 1423-1428

Spandidos Publications

Access to resources Recommend Favorite